Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02424357 · ClinicalTrials.gov registry record · NA
Suture Contamination Rate in Adjustable Suture Strabismus Surgery
A NA study of Suture Strabismus Surgery, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT02424357 is a NA study of Suture Strabismus Surgery that has completed, run by University of Miami. The registered enrollment target is 65 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02424357, a NA study of Suture Strabismus Surgery, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
1. To establish the culture positivity rate in adjustable suture strabismus surgery 2. To identify bacterial species and antibiotic susceptibility patterns of microorganisms cultured from suture material 3. To compare suture contamination rates with techniques to reduce the suture contamination rate
Conditions Studied
Interventions
- DRUG 5%povidone iodine ophthalmic solution
- DRUG routine post-operative ophthalmic ointment
Study Locations (1)
Florida
- Bascom Palmer Eye Institute, University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02424357
The ClinicalTrials.gov registry entry for NCT02424357 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suture Strabismus Surgery appearing as the primary indexed condition, and to 2 interventions - of which 5%povidone iodine ophthalmic solution is the first listed.
NCT02424357 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02424357 about?
NCT02424357 is a clinical study titled "Suture Contamination Rate in Adjustable Suture Strabismus Surgery". 1. To establish the culture positivity rate in adjustable suture strabismus surgery 2. To identify bacterial species and antibiotic susceptibility patterns of microorganisms cultured from suture material 3. To compare suture contamination rates with techniques to reduce the suture contamination rate
What is the current status of trial NCT02424357?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2015-07. Estimated completion is 2016-02.
What conditions does trial NCT02424357 study?
This clinical trial studies the following conditions: Suture Strabismus Surgery.
What interventions are being tested in trial NCT02424357?
The interventions under investigation include: 5%povidone iodine ophthalmic solution (DRUG), routine post-operative ophthalmic ointment (DRUG).
Who is sponsoring clinical trial NCT02424357?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02424357 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.